The dots show the distribution of -log10 P-values after double genomic-control correction. The expected distribution of P-values under the null hypothesis is shown by the solid black diagonal line. b) Regional association plots for 10 pubertal growth variants reaching the genome-wide significance level (1.67x10 -8 ) in discovery or joint analyses. The regional distribution of non-GC corrected P-values for discovery phase associations surrounding the most highly associated SNP in each region is shown as well as previously reported SNPs for related traits. The best pubertal growth marker is shown in yellow, while blue triangles are associated with adult stature (Lango Allen 2010), red triangles are associated with age at menarche (Elks 2010) , violet triangles are BMI markers (Speliotes 2010), and turquoise triangles are previously associated with peak height velocity 2 (PHV2) (Sovio 2009). For the LIN28B region, the leading pubertal growth marker, rs7759968, is the same marker previously reported to associate with both adult stature and age at menarche. 5 b) Regional association plots for 10 pubertal growth variants reaching the genome-wide significance level (1.67x10 -8 ) in discovery or joint analyses. The regional distribution of non-GC corrected P-values for discovery phase associations surrounding the most highly associated SNP in each region is shown as well as previously reported SNPs for related traits. The best pubertal growth marker is shown in yellow, while blue triangles are associated with adult stature 1 , red triangles are associated with age at menarche 2 , violet triangles are BMI markers 3 , and turquoise triangles are previously associated with peak height velocity 2 (PHV2) 4 . For the LIN28B region, the leading pubertal growth marker, rs7759968, is the same marker previously reported to associate with both adult stature and age at menarche.
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Supplementary figure 2. Cross-sectional charts of relative body mass index (BMI) for 10 pubertal growth signals. The effect sizes of BMI SDS against genotype at 6 age bins from pre-puberty to adulthood were plotted longitudinally across adolescence for loci a) not associated with age at menarche and b) associated with the timing of menarche. *P <0.002 Table S1 . Correlation between three measures of pubertal growth in two Finnish cohorts. Correlations were calculated pairwise between raw measurements of height or the difference in height (cm) for males and females separately in a) Northern Finland Birth Cohort 1966 (NFBC1966) and b) Cardiovascular Risk in Young Finns Study (YFS). The phenotypes were: height at 10 years in females (10F) and 12 years in males (12M), total pubertal growth from age 8 years to adult in females (PGF) and males (PGM), and late pubertal growth from age 14 years to adult in females (PTF) and males (PTM). Correlations were only calculated for individuals having data for both phenotypes being compared. P value is given for the discovery set of Analysis I for males and females combined and has been genomic control-corrected.
Supplementary table 7.
Pathway analyses for Analysis I: Height SDS at 10 yrs in females and 12 yrs in males combined. Pathway analyses are reported for Analysis I only since no significant results were revealed for analyses II and III.
a) g:Profiler results for KEGG pathways and Gene Ontology Biological Processes (GO BP).
The nearest gene to the top 0.0003% (P<1x10 -4 ) of signals associated with Analysis I was entered into the g:GOST Gene Group Functional Profiling tool 6 to look for enrichment of associated genes in biological pathways. These results were queried from http://biit.cs.ut.ee/gprofiler/index.cgi on 31 January, 2012. 
Supplementary table 12. The association between BMI loci and the relative pubertal height change from 8 to adult (Analysis II).
We queried the effect on total pubertal growth in males and females combined of previously known markers which tag loci influencing BMI 3, 10 . 
SNP

Supplementary Note 1. Cohort Descriptions Avon Longitudinal Study of Parents and Children (ALSPAC)
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a prospective study, which recruited pregnant women with expected delivery dates between April 1991 and December 1992 from Bristol UK. The study methods are described elsewhere and on the study website (www.alspac.bris.ac.uk) 1 . From age 7 years onward, the whole cohort of children was invited to attend regular research clinics where anthropometric measures were taken as described previously. DNA was collected and extracted as described previously. Before the first clinic at age at 7 years, data for height and weight comes from health visitor records. A detailed description of these measurements and their validity has been previously reported. Following this, clinic measurement of height follows at all ages. Height was measured to the last complete mm using the Harpenden Stadiometer. Children were positioned with their feet flat and heels together, standing straight so that their heels, calves, buttocks and shoulders came into contact with the vertical backboard of the stadiometer. The headboard was lowered down the backboard until it touched the child's head and a 1 kg weight was placed on the headboard to ensure head contact and to minimize the effect of hair thickness. Any problems with measuring were noted. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees.
British Birth Cohort (B58C-WTCCC and T1DGC)
The 1958 British Birth Cohort (1958BC) is a population based prospective study of all individuals born during one week in March 1958 in England, Scotland, and Wales (n=17,638) 2 . The cohort has been followed-up during childhood, at ages 7, 11, and 16 years and into adulthood, with height measured by an attending clinician at all childhood contacts. At age 45 years, 11,971 cohort members who had not died or emigrated, were invited to a biomedical assessment. In total 9,377 participants provided data, several clinical assessments (including height and weight as measured by the attending nurse) and DNA collection. . Genome-wide data for the 1958BC has been obtained through two sub-studies, both using the 1958BC members as a control population. First, 3,000 DNA samples were randomly selected as part of the Welcome Trust Case Control Consortium (WTCCC) and genotyped on the Affymetrix SNP 6.0 platform 3, 4 . Secondly, 2,592 DNA samples from the 1958BC were used as controls for a type 1 diabetes case-control study (T1DGC). Samples were genotyped through the JDRF/WT Diabetes and Inflammation Laboratory (DIL) using the Illumina Infinium 550K chip 5 .
Children's Hospital of Philadelphia (CHOP)
All subjects were consecutively recruited from the Greater Philadelphia area from 2006 to 2011 at the Children's Hospital of Philadelphia. Our study cohort consisted of children of European ancestry. All of these participants had their blood drawn into 8ml EDTA blood collection tubes that were subsequently DNA-extracted for genotyping. All subjects were biologically unrelated and were less than 18 yrs old. This study was approved by the Institutional Review Board of the Children's Hospital of Philadelphia. Parental informed consent was given for each study participant for both the blood collection and subsequent genotyping. We performed high-throughput genome-wide SNP genotyping, using the Illumina Infinium™ II HumanHap550 BeadChip technology (Illumina, San Diego), at the Center for Applied Genomics at CHOP. We used 750ng of genomic DNA to genotype each sample, according to the manufacturer's guidelines. Samples were genotyped on a combination of the HumanHap 550 version 1, HumanHap 550 Version 2 and 610 Quad SNP chips. Mach 1.0 was used to impute ~2.54 million SNPs using the CEU HapMap (release 22, build 36) haplotypes.
Copenhagen Study on Asthma in Childhood (COPSAC)
The COPSAC birth cohort study is a prospective clinical study of 411 infants born to mothers with a history of asthma. The newborns were enrolled at the age of 1 month, previously described in detail 6, 7, 8 . The study was approved by the Ethics Committee for Copenhagen (KF 01-289/96) and The Danish Data Protection Agency (2008-41-1754) and informed consent was obtained from both parents. The families used doctors employed at the clinical research unit, and not the family practitioner, for diagnosis and treatment of any respiratory or skin-related symptoms. Participants were assessed at the COPSAC clinical research unit at six monthly intervals; additional visits were arranged immediately upon the onset of symptoms. All growth parameters were measured and obtained by the COPSAC physicians at each scheduled six month visit until age 7 and history was obtained using structured questions and closed response categories. At every visit length was measured by infantometer, Kiddimetre® (Raven Equipment Limited, Essex England). From 2.5 years, height was measured using a stadiometer (Harpenden; Holtain Ltd, Crymych, Dyfed, Wales) 6 . High throughput genomewide SNP genotyping was performed using the Illumina Infinium™ II HumanHap550 v1, v3 or quad BeadChip platform (Illumina, San Diego), at the Children's Hospital of Philadelphia's Center for Applied Genomics, as described previously 9 and available in 360 children.
Finnish Twin Cohort Study (FTCS)
Within the Finnish Twin Cohort Study, FinnTwin12 (FT12) is a population based-cohort longitudinal study of five consecutive birth cohorts of Finnish twins born between 1983 and 1987 10 . All twins (and their parents) were initially contacted and invited to participate by mail in the autumn of the year in which their birth cohort reached 11 years of age. At that baseline assessment, parents filled in a questionnaire about the childhood and development of the twins, questionnaires about themselves, and the twins had brief questionnaires of their own. Height and weight were asked. The initial participation rate was 87%. Subsequent follow-up assessments were made when the twins were aged 14, 17 and ~22 years. DNA was collected as blood or saliva (Oragene kits) formed part of the assessment in young adulthood (age range 21-24 yrs) 11 . Genotyping was done using the Illumina 670 custom chip at the Sanger Institute. The FTCS has been approved by local ethics committees.
The Generation R Study (Generation R)
The Generation R Study is a population-based prospective cohort study from fetal life until young adulthood. All children were born between April 2002 and January 2006. This study is designed to identify early environmental and genetic determinants of growth, development and health from fetal life until young adulthood and has been described previously in detail 12, 13 . Detailed measurements were performed using ultrasound and physical examinations, biological samples and advanced imaging techniques. The study has been approved by the Medical Ethics Committee of the Erasmus Medical Center, Rotterdam. Written informed consent was obtained from all participants or their parent(s). Height was measured by well-trained staff in community health centers using standardised procedures at the age of 11, 24, 36 and 48 months 12 . Length was measured in a supine position to the nearest millimeter at the age of 11 months with a neonatometer, after which height was measured in standing position with a Harpenden stadiometer (Holtain Ltd, Dyfed, United Kingdom). Cord blood for DNA isolation was available in 59% of all live-born participating children. Sexmismatch rate between genome based sex and midwife-record based sex was low (<0.5%), indicating that possible contamination of maternal DNA was extremely low. Missing cord blood samples were mainly due to logistical constraints at the delivery. Individual genotype data were extracted from the genome-wide Illumina 610 Quad Array 14 .
Genome-Wide Population-Based Association Study of Extremely Overweight Young Adults (GOYA)
This study was conducted as part of the activities of the Danish Obesity Research Centre (DanORC, www.danorc.dk) and the MRC centre for Causal Analyses in Translational Epidemiology (MRC CAiTE). The cohort used here was derived from a draft board examination of men, constituted by young Danish adults with negligible admixture of other ethnicities. These men (n=180) also had yearly measurements of height and weight in school which was used in this study. The study was approved by the regional scientific ethics committee and by the Danish Data Protection Board. Genome-wide genotyping on the Illumina610 quad BeadChip was carried out at the Centre National de Génotypage (CNG), Evry, France. We carried out imputation to HapMap release 22 (CEU individuals) using Mach 1.0 Markov Chain Haplotyping.
Helsinki Birth Cohort Study (HBCS)
The Helsinki Birth Cohort Study (HBCS) is a prospective birth cohort including individuals born at the Helsinki University Central Hospital between the years 1934 and 1944. Birth records were collected on 4,630 men and 4,130 women born in this hospital and living in Finland in 1971. Serial measurements of height and weight until age 12 were extracted from child welfare clinic and school health clinic records, with an average of 10 measurements between birth and 2 years, and 8 measurements between 2 and 11 years of age. Between 2000 and 2002, were between 59 and 70 years old, a representative subset of 928 males and 1075 females returned for clinical examinations, when adult stature was measured and blood was taken for DNA extraction 15, 16 . HBCS has been approved by local ethics committees. . This project aims to study the associations between pre-and postnatal environmental exposures and growth, health, and development from early foetal life until adolescence and has been described previously in detail 17 . Pregnant women were enrolled during pregnancy at public primary health care centers or public hospitals. Detailed measurements were performed using ultrasound and physical examinations and biological samples. Informed consent was obtained from all participants and the study was approved by the Hospital Ethics Committees in each participating region.
INfancia y Medio
Analysis were restricted to Caucasian individuals with genome-wide data and a length measurement at 1 year, 2 years, 3 years, or 4 years of age (n=847). Length was measured to the nearest centimeter using a wall-mounted stadiometer with the children standing in light clothing and barefoot by well-trained staff. Sex-and age-adjusted standard deviation scores (SDS) were constructed using Growth Analyser 3.0 (http://www.growthanalyser.org; Dutch Growth Research Foundation, Rotterdam, the Netherlands). The reference curve for length in the Netherlands, 1997 was used 18 . Cord blood for DNA isolation was available for 899 out of 1477 (60.9%) samples of all live-born participating children from INMA-Sabadell and INMA-Valencia. Whole blood DNA collected at age 4y or saliva DNA at age 4y was available for 432 out of 482 (89%) children from INMA-Menorca. A subset of 932 samples was selected for the genome-wide genotyping using the HumanOmni1-Quad Beadchip (Illumina). After sample QC, the number of samples available for the GWAS analysis was 925. Sex-mismatch rate between genome based sex and midwife-record based sex was 0, indicating that possible contamination of maternal DNA was extremely low.
Lifestyle-Imune System-Allergy plus environment and genetics study (LISAplus) and German Infant Study on the influence of Nutrition Intervention plus environment and genetics (GINIplus)
The influence of Life-style factors on the development of the Immune System and Allergies in East and West Germany PLUS the influence of traffic emissions and genetics (LISAplus) Study is a population based birth cohort study. A total of 3,097 healthy, mature (gestational age over 37 weeks) neonates with a birth weight over 2500g were recruited between 1997 and 1999 in Munich, Leipzig, Wesel and Bad Honnef. A total of 5,991 mothers and their newborns were recruited into the German Infant study on the influence of Nutrition Intervention PLUS environmental and genetic influences on allergy development (GINIplus) between September 1995 and June 1998 in Munich and Wesel. Detailed descriptions of the LISAplus and GINIplus studies have been published elsewhere 19, 20 . Weight and height were measured in both studies at age 1 week, 1 month, 3 months, 6 months, 2, 4, and 5 years by the family physician and at age 10 years by the physician of the study at a clinical examination or by the parents. For both studies, approval by the local Ethics Committees and written consent from participant's families were obtained. In the discovery analysis, only children from the LISAplus study from Munich were included. DNA was analyzed using the Affymetrix Human SNP Array 5.0 for each individual. Genome-wide data was called using BRLMM-P algorithm and imputed after quality control (MAF>1%, HWE>0.01, call rate per SNP and person >95%) in IMPUTE. Genome-wide association analysis was carried out in SNPTEST V2. For replication, two independent subsets of children from Munich from both studies with genome-wide data were included, one with information on gestational age and one without. Individuals were analyzed using the Affymetrix Human SNP Array 5.0 and 6.0. Genotypes were called using BRLMM-P algorithm (5.0), respectively BIRDSEED V2 algorithm (6.0), imputed after quality control (MAF>1%, HWE>1e-05, heterocygocity 4SD, call rate per SNP and person >95%) in IMPUTE2 and genome-wide association analysis was carried out in SNPTEST V2.
Northern Finland Birth Cohort 1966 (NFBC1966)
The Northern Finland Birth Cohort study 1966 (NFBC1966) is a prospective cohort study, including 12,058 individuals with expected dates of birth during 1966 from Oulu and Lapland, the two northernmost provinces of Finland, representing 96% of all births in these provinces 21, 22 . Study participants were followed up at 6 months, 1, 14, and 31 years old, and extended childhood growth measurements were collected from records taken by school health care clinics and archived by communal health clinics. Height at age 14 was gathered from questionnaires mailed to the adolescents and was self-reported. Individuals still living in northern Finland or in the capital area were invited to a clinical examination at age 31 years. At this visit, height and weight were measured, and a blood sample was taken for DNA extraction. Participants provided written informed consent. The University of Oulu Ethics Committee and the Ethical Committee of Northern Ostrobothnia Hospital District approved the study.
Northern Finland Birth Cohort 1986 (NFBC 1986)
The Northern Finland Birth Cohort 1986 includes 9,432 children with expected dates of birth between July 1, 1985 and June 30, 1986 , in the two northernmost provinces of Finland, Oulu and Lapland 23 . Yearly height and weight measurements were obtained from communal child health clinics, and participants were invited to a clinical examination at the age of 15 to 16 years when blood was taken for DNA extraction. DNA was extracted for 6,266 participants. Participants provided written informed consent. The University of Oulu Ethics Committee and the Ethical Committee of Northern Ostrobothnia Hospital District have approved the study.
Netherlands Twin Register (NTR)
The Netherlands Twin Register (NTR) is a large population based study that includes approximately 40% of all multiple births in the Netherlands since 1986 24 . Data on height at age 10 and 12 have been collected through mailed surveys 25 . In NTR subsamples, height was measured by a nurse or research assistant. When self-reported and measured height was available, measured height was analyzed. Blood and/or buccal samples for DNA extraction were collected in a number of projects. Genotyping was performed on the Affymetrix Human SNP Array 6.0 in the Avera Institute, Sioux Falls, South Dakota (USA). Genotypes were called using the BIRDSEED V2 algorithm. SNPs were imputed in BEAGLE at the MD Anderson Cancer Center, Houston, Texas (USA). In case individuals had multiple samples genotyped, the sample with the highest quality was selected. In monozygotic twin pairs, one individual was selected at random. For other family relations (dizygotic twins/siblings) all data were retained. Analyses were performed in Plink using the -within option with family number as cluster variable to correct for the relatedness within families. Study protocols were approved by the medical ethics board of the VU Medical Center Amsterdam, the Netherlands. The METc VUmc is registered with the US Office of Human Research Protections as IRB number IRB00002991.
The prevention and incidence of asthma and mite allergy birth cohort study (PIAMA)
The PIAMA study is a birth cohort study of children born between 1996-1997. Details of the study design have been published previously 26 . 10,232 pregnant women completed a validated screening questionnaire at their prenatal health care clinic (n=52). Based on this screening, 7,862 women were invited to participate, of whom 4,146 women agreed and gave informed consent. Mothers reporting a history of asthma, current hay fever or allergy to pets or house dust mite were defined as allergic. Children were recruited during the first trimester of pregnancy. Follow-up of the children took place at 3 months of age and yearly from 1 to 8 years of age. At eight years of age, all children were invited to clinical testing including collection of blood samples for DNA extraction. The Medical Ethical Committees of the participating institutes approved the study, and all participants gave written informed consent. The response rates to the annual questionnaires ranged from 3,764 at age 1 to 3,269 at age 8 years. For the GWAS, DNA from childhood asthma cases (children who have ever had a doctor's diagnosis of asthma at age 8 years) and a set of non-asthmatic controls (children who never had a doctor's diagnosis of asthma and who have never wheezed at age 8 years) were provided.
Queensland Institute of Medical Research (QIMR)
The QIMR adolescent sample is a population-based cohort from Brisbane, Australia, previously described in detail 27 . Twins are recruited through schools and the media. The data used in this study is from an ongoing study of the genetic influences on mole count. Twins come to the facility at age 12 and have their height measured by a nurse in addition to having their moles counted. This study commenced in 1992 and year of birth ranges from 1979-1996. A total of 2,247 twins have had their height measured at age 12. Only males with gentotype information are used in the present study. The study was approved by the QIMR Human Research Ethics Committee.
Western Australia Pregnancy Study (RAINE)
Recruitment of the Western Australian Pregnancy (RAINE) cohort has previously been described in detail 28, 29, 30 . In brief, between 1989 and 1991, 2,900 pregnant women were recruited prior to 18-weeks gestation into a randomised controlled trial to evaluate the effects of repeated ultrasound in pregnancy. Children have been comprehensively phenotyped from birth to 21 years of age (average ages of one, two, three, six, eight, ten, fourteen, seventeen and twenty-one) by trained members of the Raine research team. Most of the children are of Caucasian ethnicity. Data collection included questionnaires completed by the child's primary carer and by the adolescent from age 14, physical assessments by trained assessors at all follow up years, and DNA collection from year 14 follow-up. The study was conducted with appropriate institutional ethics approval, and written informed consent was obtained from all mothers. Study individual genotype data was extracted from the genome-wide Illumina 660 Quad Array.
Cardiovascular Risk in Young Finns Study (YFS)
Cardiovascular Risk in Young Finns (YF) is an ongoing collaborative study between five Finnish university medical schools (Helsinki, Turku, Oulu, Kuopio, and Tampere) of risk factors for atherosclerosis 31, 32 . The baseline cross-sectional study was carried out in 1980, including 3596 subjects at ages 3, 6, 9, 12, 15, and 18. Between 1980 and 1992, these subjects were followed up at 3-year intervals, and then as adults in 2001 and 2007. Height and weight were measured at each clinical visit, and adult stature was measured between ages 24 and 42. The study was approved by local ethics committees.
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